Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × N,N-dicyclohexyl-isoborneol-10-sulfonamide × 90 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Accelerated Phase 1 Down Syndrome 1 Blast Crisis 1

Interventions

Dexamethasone 15 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 pomalidomide 10 venetoclax 9 fludarabine 9 Lenalidomide 8 Calcium Dobesilate 7 glofitamab 6 Gemcitabine 6 Cytarabine 6 carfilzomib 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 Bortezomib 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 blinatumomab 3 belantamab mafodotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡